Potential US pharma import tariffs could raise prices, stifle innovation, and revolutionise how the industry produces drugs.

The head of drugmaker Eli Lilly, which sells the popular weight-loss drug Zepbound, urged the Trump administration to ease up on its tariff rollout because it could hurt Lilly’s business and the ...

The county joins municipalities across the country suing Eli Lilly, CVS Caremark, and others for sky-high prices.

US drug prices are up to five times higher than in other developed nations. Trump's order requires US drug prices to align ...

Analysts are still crunching the numbers on the impact of President Donald Trump's executive order from Monday on drug pricing. HSBC analyst Rajesh Kumar says a 20% price cut in government channels ...

The obesity drug helped people trim about two inches more off their waists than Wegovy in the first head-to-head study of the ...

The same official said the administration doesn't "anticipate a negative impact on innovation ... such as Eli Lilly's ...

Global pharmaceutical shares are slumping Monday after President Donald Trump said he is looking to slash the price of ...

Announcement pressures pharma stocks on worries profits will be hit if they have to cut prices in US. Read more at ...

Global pharmaceutical stocks took a hit on Monday after U.S. President Donald Trump pledged to slash prescription prices by ...

Shares of pharmaceutical companies fell across the world after US President Donald Trump said he planned to order a cut in US ...

Shares of Alphamab Oncology plunged 14.4% to HK$6.28, leading declines in Hong Kong-listed pharmaceutical stocks.Meanwhile, ...